title: The behaviour of blood lymphocyte subsets in patients treated with immunochemotherapy for metastatic melanoma.
authors.affiliation: Clinical Pathology Laboratory, Regina Elena National Institute of Cancer, Rome, Italy.
authors.forename: V
authors.initials: V
authors.lastname: Francavilla
authors.forename: M C
authors.initials: MC
authors.lastname: Arista
authors.forename: S
authors.initials: S
authors.lastname: Carpano
authors.forename: F
authors.initials: F
authors.lastname: Valente
authors.forename: M
authors.initials: M
authors.lastname: Vercillo
authors.forename: L
authors.initials: L
authors.lastname: De Franceschi
authors.forename: L
authors.initials: L
authors.lastname: Conti
authors.forename: M
authors.initials: M
authors.lastname: Lopez
mesh_terms: D015703:Antigens, CD / Q000032:analysis; D003606:Dacarbazine / Q000627:therapeutic use; D005260:Female; D005434:Flow Cytometry; D006684:HLA-DR Antigens / Q000032:analysis; D006801:Humans; D016130:Immunophenotyping; D007376:Interleukin-2 / Q000627:therapeutic use; D016131:Lymphocyte Subsets / Q000166:cytology; D008297:Male; D008545:Melanoma / Q000276:immunology* / Q000556:secondary / Q000628:therapy; D008875:Middle Aged
chemical_list: D015703:Antigens, CD; D006684:HLA-DR Antigens; D007376:Interleukin-2; D003606:Dacarbazine